Evaluation of the safety and immunogenicity of a new tuberculosis vaccine, MVA85A, as a booster vaccine for BCG, in a series of Phase II clinical trials in South Africa. (360G-Wellcome-081122_Z_06_Z)
Funding Organization
£1,538,228
Recipient Organization
Do not Publish
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 1538228 |
| Applicant Surname | McShane |
| Approval Committee | Innovations Strategy Panel |
| Award Date | 2006-09-28T00:00:00+00:00 |
| Financial Year | 2005/06 |
| Grant Programme: Title | Strategic Translation Award |
| Internal ID | 081122/Z/06/Z |
| Lead Applicant | Prof Helen McShane |
| Other Applicant(s) | Prof Gregory Hussey |
| Partnership Value | 1538228 |
| Planned Dates: End Date | 2008-09-30T00:00:00+00:00 |
| Planned Dates: Start Date | 2006-10-01T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | South East |